Investing.com - Stocks in focus in premarket trade Thursday:
• Apple (NASDAQ:AAPL) stock plummeted 8.26% by 8:07 AM ET (13:07 GMT) after the company cut its quarterly sales forecast due to the economic slowdown in China.
• Celgene (NASDAQ:CELG) stock soared 33.15% after Bristol-Myers Squibb (NYSE:BMY) announced plans to buy the company for $74 billion.
• Starbucks (NASDAQ:SBUX) stock traded down 1.15% as Chinese rival Luckin announced plans to open 2,500 stores this year and overtake the company as the largest coffee chain in the world’s second-largest economy.
• Johnson & Johnson (NYSE:JNJ) stock dropped 0.83% after a regulatory filing showed that the company’s sales in India had fallen 3% in the year up to March 2018.
• Amgen (NASDAQ:AMGN) stock lost 0.86% as the company announced a settlement with Teva Pharma (NYSE:TEVA) over its kidney disease drug in which it will receive a payment while Teva also stops selling its generic version until mid-2021.
• Coca-Cola (NYSE:KO) stock lost 0.70% after the European Commission approved its acquisition of Costa Coffee.
• Humana (NYSE:HUM) stock could see movement in the regular session after an SEC filing showed that the company plans to reiterate its 2018 earnings guidance at its investor meeting. The forecast is slightly below consensus.
• IZEA (NASDAQ:IZEA) stock surged 26.10% after the company announced that it was awarded “multiple significant contract wins in December”.
• Tribune Media (NYSE:TRCO) stock may see movement in the regular session as it pulled its television channels from Charter Spectrum after a deadline passed over its carriage dispute.